Overview

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure

Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the adhesion performance and pharmacokinetics of ZTlido (lidocaine topical system) 1.8% during swimming, showering, and under normal conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Scilex Pharmaceuticals, Inc.
Treatments:
Lidocaine